BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 22, 2026
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

April 15, 2021

View Archived Issues
Test tubes

C2i Genomics raises $100M in series B to advance residual cancer detection technology

Anyone who has had a malignant tumor removed knows the anxiety that follows. Did any traces of cancer remain, and if it returns, will doctors catch it before it’s too late? To reduce the uncertainty and improve patient outcomes, C2i Genomics Inc. has raised a $100 million series B funding round led by Casdin Capital to advance software that is 100 times more sensitive in detecting residual disease than legacy technologies. Read More
OCT image

FDA grants breakthrough device designation for Perimeter’s AI-assisted OCT

Just six weeks after receiving FDA 510(k) clearance for its optical coherence tomography (OCT) imaging system (v2.1), Perimeter Medical Imaging AI Inc. received breakthrough device designation from the FDA for its next-gen product, the OCT imaging system with integrated artificial intelligence (AI). Read More
US-budget-spending-money.png

Becerra: ARPA-H a translational research office, but some see redundancy

The Biden administration’s fiscal 2022 budget proposal included an allocation for an office described as the Advanced Research Projects Agency – Health, or ARPA-H, which would receive $6.5 billion as part of the National Institutes of Health. Read More
3-24-electrocore-gammacore-sapphire.png

Canadian approval of headache therapy more validation for Electrocore, new business model for RSK Medical

TORONTO – For Scott Kadwell, president of Markham, Ontario-based RSK Medical Inc., the distributor tagged to sell the Health Canada approved Gammacore Sapphire, the device represents “a shift from a business to business to a direct-to-consumer business model.” For Rockaway, N.J.’s Electrocore Inc. which developed the self-administered technology, it’s one more regulator to have greenlighted the FDA cleared, CE-marked device for treating intractable migraine and cluster headache. Read More
Illustration of pill being analyzed

Stonewise raises $100M in B and B+ rounds to advance AI-enabled drug discovery

HONG KONG – Beijing Stonewise Technology Co. Ltd., a med-tech firm that uses artificial intelligence (AI) to aid in the discovery of small molecule drugs, closed series B and B+ financing rounds that added $100 million to its pocket. The company intends to use the proceeds to upgrade its AI-enabled drug discovery platform. Read More

Appointments and advancements for April 15, 2021

New hires and promotions in the med-tech industry, including: 100 Plus, Angiosoma, Butterfly Network, Clover Health, Inflammatix, Nemaura, Neopenda, Revibe, Suralign. Read More

Financings for April 15, 2021

Med-tech firms raising money in public or private financings, including: Imageens, Medable, Rapha Capital Management, Revibe Technologies, Spectral Medical. Read More

In the clinic for April 15, 2021

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abiomed, Castle Biosciences, Gynesonics, Nanoview Biosciences. Read More

Other news to note for April 15, 2021

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, ATMPS, Biolq, Biostem Technologies, Blue Cross Blue Shield of Massachusetts, Canon Medical, Cloud Dx, Consonance-HFW, D8 Holdings, EBR Systems, Emblemhealth, Fionet, Geninus, Helixrus, Implicity, Mindmaze Healthcare, MLU Services, Ori Biotech, Powerdot, PPD, Procept Biorobotics, Raysearch, Relay Medical, Resolution Bioscience, Rosalind, Soliton, Surrozen, Therabody, Thermo Fisher Scientific, Vicarious Surgical. Read More

Regulatory actions for April 15, 2021

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Perimeter Medical Imaging AI. Read More

Regulatory front for April 15, 2021

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: FDA reverses HHS premarket notification exemptions; ITC will check findings for Zimmer/Heraeus dispute. Read More

BioWorld MedTech’s Diagnostics Extra for April 15, 2021

Keeping you up to date on recent developments in diagnostics, including: Imbalance in gum bacteria linked to Alzheimer-related protein in healthy adults; Tiny device monitors deep-tissue oxygen. Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • MRI image brain on black background

    ADPD 2026: Can we prevent dementia? Scientists quantify it

    BioWorld
    Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • Illustration of Alzheimer's disease in the brain

    ADPD 2026: Three inflection points to target Alzheimer’s disease

    BioWorld Science
    A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing